DUDE CHEM

We're thrilled to announce that DUDE CHEM has been featured in Handelsblatt, one of Germany's leading business publications! This spotlight gives us a fantastic opportunity to share our mission with a wider audience: revolutionizing the pharma-chemical industry through green chemistry and bringing manufacturing back to Europe. At DUDE CHEM, we actively work on building a more sustainable and competitive European industry. Our CEO, Sonja Jost, shared our vision for transforming chemical manufacturing, the challenges that lie ahead and the opportunities we must seize. We believe that the chemical industry is ripe for disruption and we strive for a competitive European landscape. Our approach combines the best of traditional knowledge with modern technological advancements, creating new ways to produce the chemical product our society needs – from our home base Berlin into the world. We're grateful for the chance to spread our message and inspire others to join the green chemistry revolution. To our partners, customers, and fellow innovators: thank you for being part of this journey. Together, we're proving that it's possible to produce high-quality pharmaceuticals at compey costs while prioritizing environmental responsibility. #GreenChemistry #DUDECHEM #Press #Innovation

Today, our CSO Henriette was invited by Shimadzu Deutschland GmbH to hold a webinar for their customers and their broader network: "Green Process Development for a Greener Supply of Pharmaceuticals (APIs)." During the webinar, Henriette demonstrated how we incorporate the 12 principles of green chemistry into drug synthesis and analytical development using a real-world case study. It was an exciting opportunity to showcase how DUDE CHEM is leading the change toward a greener pharmaceutical industry. As one of the global experts in industrial manufacturing of chemicals in water, Henriette gave valuable insights on how to substitute oil-based toxic solvents in a very cost-efficient way. Henriette, DUDE CHEM Chief Scientific Officer: "Reactions in water don't depend on expensive designer surfactants. With the right toolbox, you can easily apply FDA approved pharma surfactants, beyond others." Dr. Michael Schulze Shimadzu Deutschland GmbH: "It was impressive to see the broad range of applicability of reactions in water. We are committed to support companies such as DUDE CHEM on their journey to make the industry greener.” At DUDE CHEM, we are challenging the status quo. We take immense pride in developing sustainable chemical processes that align with Europe's green goals. We believe in leading by example, and we’re honored that our ongoing work is recognized by key industry players such as Shimadzu. This collaboration reinforces our commitment to sustainability and innovation in the chemical sector. #GreenChemistry #Pharmaceuticals #Sustainability

Green Chemistry is emerging as a powerful solution—offering the potential to not only reduce environmental impact but also drive significant cost savings and enhance competitiveness. In our latest article, we delve into how DUDE CHEM is challenging the status quo by optimizing existing infrastructure and partnering with manufacturers across Europe. We're proving that sustainability and profitability can go hand in hand, and that the future of Europe's chemical industry lies in #green #chemistry. Read the full article to discover how we're making this vision a reality:

We’re excited to share that our team is growing, and we’ve recently welcomed some incredible new talent from across the globe, including our newest member, Juan Pablo who joined us as Junior Analytical Chemist. He is originally from Colombia, had been living in Spain, and has now shifted his base to Berlin to join us. A special shoutout to the #German #Embassy in #Madrid for their swift and efficient assistance to Juan in securing his #EU #Blue #Card. According to him, the process was seamless, and we deeply appreciate the support that made this transition smooth for our new colleague. At DUDE CHEM, we are proud of our #diverse and dynamic team, which now includes 23 employees from 12 different #nationalities. This diversity is not just a statistic—it’s a driving force behind our innovation and success. We believe that bringing together the best minds from around the world is key to fostering a creative and inclusive work environment where everyone can thrive. As we continue to grow, we remain dedicated to building a team that represents the best of the #best, no matter where they come from. If you’re passionate about making an impact in the chemical industry and want to be part of a forward-thinking, inclusive team, we’d love to hear from you. Thank you again to the German Embassy in Madrid for your exceptional service, and here’s to many more milestones together as we continue to expand our international family! #Diversity #InternationalTalent #ThankYou #EUBlueCard #Hiring #greenchemistry #DUDECHEM

Join me in the GCTLC forums for an exciting “Ask Me Anything” interview- with you as the interviewers! From Sept. 3 to Sept. 6, post any questions in the “AMA” forum space. I’ll be on hand to answer your questions (time permitting!) Stay tuned for more information!   Not familiar with the GCTLC? An initiative by Beyond Benign—Green Chemistry for a Sustainable Future, in collaboration with partners such as the ACS Green Chemistry Institute(r) and green chemistry leaders and educators worldwide, the GCTLC is a dynamic virtual space where community members can develop connections, find mentors, share resources, and enhance their knowledge through peer-led learning. We encourage you to join this one-stop shop for everything #GreenChemistry education! (https://lnkd.in/erm6Mc8r) 

Q&A with the new CFO! Dr. Marion Trautbeck-Kim brings a wealth of experience in finance and law to DUDE CHEM, with a career that spans both startups and established companies. Her expertise is already making a significant impact as we continue to push the boundaries of #green #chemistry. Today, Marion shares her thoughts on joining DUDE CHEM and what lies ahead for the company and the broader chemical industry. Q: What excites you most about joining DUDE CHEM at this stage of its growth? Marion: "What thrills me most about DUDE CHEM is the opportunity to be part of an industry that's ripe for change. The chemical sector has long been considered traditional, but there's a wave of innovation sweeping through, especially around sustainability. DUDE CHEM isn’t just adapting to these changes; it's leading them. It’s an exciting time, and being part of a team that’s genuinely setting #new #standards in green chemistry was a chance I couldn’t pass up." Q: As you step into your role, what are your main priorities? Marion: "My focus is on building on the strong foundation that’s already here. DUDE CHEM has garnered significant interest from top investors, and I’m excited to help steer that momentum into meaningful, long-term partnerships. It’s about finding the right investors who share our vision and can help us #scale in a way that stays true to our values. I'm particularly excited about creating a robust financial framework that not only supports our growth but also reinforces our commitment to environmental and societal impact." Q: How do you see the role of leadership, particularly as a #female #leader, in driving innovation in the chemical industry? Marion: "Leadership in this industry, for me, is about collaboration and inclusion. I’ve always believed that diverse perspectives lead to better decisions and more innovative solutions. What’s special about the chemical industry, and DUDE CHEM in particular, is the way leaders, especially female leaders, support each other. For example, the former CFO of Evonik has been a great mentor to our CEO, Sonja Jost and recommended her to the 'A-Seat-At-The-Table' initiative. It’s this kind of camaraderie that drives real progress, and it’s something I’m proud to be a part of." Q: What message would you like to share with investors about the future of the chemical industry? Marion: "The chemical industry is at a turning point, and it’s an incredibly exciting space for investors right now. DUDE CHEM is not just responding to changes, it's at the forefront, driving them. We’ve developed innovative processes that reduce wastes up to 70% and CO2 emissions by 40%, which is not just good for the environment but also makes smart business sense. Investing in DUDE CHEM is an opportunity to be part of a green revolution. We’re reimagining what’s possible in the industry, and I’m confident that the best is yet to come.” Thank you so much for your time, Marion! #innovation #sustainability #dudechem #cfo

Why Pharma companies are struggling with Regulatory Pressures in EU? The European Union's ambitious goal of achieving carbon neutrality by 2050 has ushered in a new era of regulatory changes for the chemical industry. While these initiatives promise a more sustainable future, they've also created a complex landscape for pharmaceutical companies to navigate. At the heart of this regulatory shift is the EU's Chemicals Strategy for #sustainability, a comprehensive plan aimed at fostering a toxic-free environment. This strategy, along with the established #REACH regulations and the new One Substance, One Assessment initiative, forms a triad of challenges for the industry. The Chemicals Strategy pushes for innovation in safer, more sustainable chemical alternatives, while REACH demands rigorous evaluation and documentation to protect human and environmental health. Meanwhile, the #One #Substance, #One #Assessment approach aims to streamline evaluations, enhancing both transparency and efficiency. For pharma companies, these changes translate into significant operational impacts. Compliance costs have skyrocketed as firms invest heavily in testing, documentation, and product reformulation. The pressure to innovate has intensified, driving up R&D expenses but also spurring technological advancements. Supply chains are undergoing scrutiny and restructuring to meet new sustainability criteria. In this challenging environment, DUDE CHEM has emerged as a beacon of innovation. Our asset-light model offers a unique approach to meeting these regulatory demands. We've developed a three-pronged strategy to help pharmaceutical companies thrive: 1. Agile Compliance: Our nimble approach allows for swift adaptation to regulatory changes, minimizing downtime and ensuring continuous compliance. 2. Green Chemistry Innovation: We're pioneering compliant "green recipes" that not only meet regulatory standards but significantly reduce environmental impact. Our processes cut waste and CO2 emissions significantly compared to industry norms. 3. Data-Driven Optimization: By leveraging data, we continuously refine our processes, boosting both efficiency and compliance in real-time. At DUDE CHEM, we're not just meeting regulatory requirements – we're setting new benchmarks for sustainability and safety in the chemical industry. As the regulatory landscape continues to evolve, we remain committed to leading the charge in #green #chemistry, helping EU pharma companies not just survive, but thrive in this new era of sustainable production. Join us in shaping a #greener future for the pharmaceutical industry. Together, we can turn regulatory challenges into opportunities for innovation and growth. #SustainablePharma #GreenChemistry #EURegulations #InnovationInChemistry #DUDECHEM

𝗚𝗿ü𝗻𝗲 𝗣𝗿𝗼𝘇𝗲𝘀𝘀𝗲𝗻𝘁𝘄𝗶𝗰𝗸𝗹𝘂𝗻𝗴 𝗳ü𝗿 𝗲𝗶𝗻𝗲 𝘂𝗺𝘄𝗲𝗹𝘁𝗳𝗿𝗲𝘂𝗻𝗱𝗹𝗶𝗰𝗵𝗲𝗿𝗲 𝗩𝗲𝗿𝘀𝗼𝗿𝗴𝘂𝗻𝗴 𝗺𝗶𝘁 𝗔𝗿𝘇𝗻𝗲𝗶𝗺𝗶𝘁𝘁𝗲𝗹𝗻 (𝗔𝗣𝗜𝘀) 🗣 Sonja Jost & Henriette Nowothnick, von der DUDE CHEM GmbH aus Berlin Dude Chem ist ein virtueller Deep-Tech-Hersteller, der eine umweltfreundlichere Versorgung mit Arzneimitteln (APIs) und deren Zwischenprodukten ermöglicht. Unser Ziel ist es, die derzeitige pharmazeutische Industrie in einen umweltfreundlichen Sektor zu verwandeln. Die 12 Prinzipien der Grünen Chemie leiten uns bei unserer täglichen Arbeit in allen Bereichen unserer Unternehmensprozesse. In diesem Webinar werden die grünen Aspekte bei der Bewertung der Wirkstoffsynthese und der analytischen Entwicklung (CoA) anhand eines Fallbeispiels aufgezeigt. ➡ 𝗠𝗲𝗹𝗱𝗲𝗻 𝗦𝗶𝗲 𝘀𝗶𝗰𝗵 𝗵𝗲𝘂𝘁𝗲 𝗻𝗼𝗰𝗵 𝗮𝗻! ⬅ Zur Anmeldung: https://lnkd.in/dgsphpqa #Mobilität #Wasserstoff #Wasserstoff #Innovation #Seminar

Why Pharma companies are struggling with Regulatory Pressures in EU? The European Union's ambitious goal of achieving carbon neutrality by 2050 has ushered in a new era of regulatory changes for the chemical industry. While these initiatives promise a more sustainable future, they've also created a complex landscape for pharmaceutical companies to navigate. At the heart of this regulatory shift is the EU's Chemicals Strategy for #sustainability, a comprehensive plan aimed at fostering a toxic-free environment. This strategy, along with the established #REACH regulations and the new One Substance, One Assessment initiative, forms a triad of challenges for the industry. The Chemicals Strategy pushes for innovation in safer, more sustainable chemical alternatives, while REACH demands rigorous evaluation and documentation to protect human and environmental health. Meanwhile, the #One #Substance, #One #Assessment approach aims to streamline evaluations, enhancing both transparency and efficiency. For pharma companies, these changes translate into significant operational impacts. Compliance costs have skyrocketed as firms invest heavily in testing, documentation, and product reformulation. The pressure to innovate has intensified, driving up R&D expenses but also spurring technological advancements. Supply chains are undergoing scrutiny and restructuring to meet new sustainability criteria. In this challenging environment, DUDE CHEM has emerged as a beacon of innovation. Our asset-light model offers a unique approach to meeting these regulatory demands. We've developed a three-pronged strategy to help pharmaceutical companies thrive: 1. Agile Compliance: Our nimble approach allows for swift adaptation to regulatory changes, minimizing downtime and ensuring continuous compliance. 2. Green Chemistry Innovation: We're pioneering compliant "green recipes" that not only meet regulatory standards but significantly reduce environmental impact. Our processes cut waste and CO2 emissions significantly compared to industry norms. 3. Data-Driven Optimization: By leveraging data, we continuously refine our processes, boosting both efficiency and compliance in real-time. At DUDE CHEM, we're not just meeting regulatory requirements – we're setting new benchmarks for sustainability and safety in the chemical industry. As the regulatory landscape continues to evolve, we remain committed to leading the charge in #green #chemistry, helping EU pharma companies not just survive, but thrive in this new era of sustainable production. Join us in shaping a #greener future for the pharmaceutical industry. Together, we can turn regulatory challenges into opportunities for innovation and growth. #SustainablePharma #GreenChemistry #EURegulations #InnovationInChemistry #DUDECHEM

What Do #Nigeria and #Europe Have in Common When it Comes to Dependencies in Drug Manufacturing? I've been closely following the global challenges in drug manufacturing for years. An article from Nigeria caught my attention, highlighting the country’s struggle with local drug production and its heavy reliance on pharmaceutical ingredients manufactured abroad. It struck me how similar these challenges are to those we currently are facing here in Germany and all over Europe. Most of our families and friends have already been confronted with shortages of important medicine for years. Despite the differences in scale and resources, both Nigeria and Europe share this #vulnerability: A dependence on Asia for many drugs. The fragility of our supply chains is a wake-up call. Encouragingly, both are beginning to address these challenges. Nigeria is pushing for intervention funds to boost local drug production, aiming to reduce dependency and build a more resilient pharmaceutical industry. Europe, too, is reassessing their position with "Made in Europe" initiatives and the EU's strategic focus on pharmaceutical sovereignty. However, matching the cost-competitiveness of Asian markets remains a significant hurdle. Europe and in particular Germany have the potential to lead in this space, but it requires bold investments in innovations and a commitment to building a more self-reliant pharmaceutical sector. Local scientific spinoffs play a crucial role here. By leveraging their expertise and fostering innovation, we can reduce our dependency on external sources and create a more #secure and sustainable future for drug manufacturing. The challenges are significant, but so are the opportunities. It’s time to turn these vulnerabilities into strengths by supporting and scaling the innovations that will drive the next era of pharmaceutical manufacturing. #PharmaceuticalSovereignty #SupplyChain #SustainableManufacturing #DUDECHEM #criticalinfrastructure